Book Value per Share: ACADIA Pharma (ACAD)

ACADIA Pharmaceuticals (ACAD) - corporate logo

The market trend for ACADIA Pharmaceuticals (ACAD), visualized in monetary terms, relies on the implementation of automated systems in preclinical molecule screening, where the indicator stands at 7.54. The business is fighting for leadership in patent disputes over CNS drugs, striving for a monopoly. High authority among specialized physicians confirms its status as an innovator creating unique treatments for patient health recovery.

ACADIA Pharma (ACAD) Equity per Share: for the period 07/04/2022 - 10/27/2026

acadia-pharm.com - analytical breakdowns and key metrics (ACAD)

- price and consensus price forecast:
Stock Price ACADIA Pharmaceuticals Inc|ACAD - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization ACADIA Pharmaceuticals Inc.|ACAD - Business Value
- book capitalization data:
Net Assets per Single Share ACADIA Pharmaceuticals|ACAD - Accounting Capitalization|Market Capitalization to Book Value Ratio acadia-pharm.com|ACAD - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio ACADIA Pharmaceuticals|ACAD - Long-Term Debt to Capital|Short-Term Debt to Equity ACADIA Pharmaceuticals Inc.|ACAD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio ACADIA Pharmaceuticals Inc.
Fundamental company valuation:ACADIA Pharmaceuticals Inc, ACAD
Manufactured products of ACADIA Pharmaceuticals Inc.

The stable R&D staff at ACADIA Pharmaceuticals (ACAD) directly impacts the dynamics of the estimated book value per share. This indicator determines the real value of equity minus all liabilities. The metric is calculated by dividing net assets by the number of shares outstanding. The growing trend confirms the effectiveness of income capitalization during a period of tight Fed policy. However, a significant divergence of the market price from this value signals a risk of overpaying for the asset.

Competitors of ACADIA Pharmaceuticals (ACAD)

Biogen Corp - Book Value per Share|NBIX - Book Value per Share|Book Value per Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share Xenon (XENE)|Equity per Share Viking Therapeutics Inc|Supernus Pharma - Book Value per Share|Net Asset Value per Share Catalyst Corp CPRX|Accounting Value per Share DNLI (Denali Therapeutics)|harmonybiosciences.com - Book Value per Share|Net Assets per Single Share Biohaven (BHVN)|AMLX: Accounting Value of a Share|Net Assets per Single Share TRVI|Praxis Corp (PRAX) - Net Asset Value per Share|AVXL (Anavex Life Sciences) - Book Value per Share|Book Value per Share ceribell.com|Book Value per Share PRTA (Prothena Biosciences)|Accounting Value per Share alector.com (ALEC)|Book Value per Share ANNX (Annexon Inc.)|Book Value per Share Omeros Corp OMER|Neurogene Inc. (NGNE) - Book Value per Share|ACIU - Equity per Share|Voyager Therapeutics, Inc. - Book Value per Share|Neumora (NMRA) - Net Assets per Share|SCLX (Scilex Holding Co.) - Book Value per Share|Book Value per Share Tevogen Bio Inc. (TVGN)|Alpha Cognition (ACOG) - Accounting Value per Share|Accounting Value of a Share CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. (IKT) - Net Assets per Single Share|Share Book Value Cassava Sciences Inc SAVA|Book Value per Share Assertio Therapeutics (ASRT)|COYA - Accounting Value of a Share|VTGN: Book Value per Share|OVID (Ovid Therapeutics) - Book Value per Share|ABOS - Net Assets per Single Share|Accounting Value of a Share CRVO|Net Assets per Single Share ATHE (Alterity Therapeutics)|Accounting Value per Share clene.com (CLNN)|Book Value per Share PEPG (PepGen)|Book Value per Share Jupiter Neurosciences, Inc. JUNS|RLMD: Book Value per Share|ANVS - Accounting Value per Share|Book Value per Share GRCE|Net Asset Value per Share Firefly Neuro|KLTO (ANEW Medical) - Accounting Value per Share|Book Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share Reviva Pharmaceuticals Holdings, Inc.|Book Price of a Share metaviatx.com (MTVA)|Book Value per Share NRXS|Net Assets per Share Helius Medical Technologies, Inc. HSDT|PASG: Book Value per Share|NEUP - Accounting Value per Share|NERV: Book Value per Share|ATHA (Athira Pharma Inc) - Book Value per Share|Net Assets per Single Share Addex Therapeutics, Ltd.|Net Assets per Single Share ALZN|CYCN (Cyclerion Therapeutics) - Net Assets per Single Share|Net Assets per Share protagenic.com (PTIX)|Book Value per Share KTTA (Pasithea Therapeutics Corp.)|Book Value per Share Cortigent Inc CRGT|ATXI: Book Value per Share|BCLI - Accounting Value per Share|CARA: Book Value per Share|chromocell.com (CHRO) - Book Value per Share|Book Value per Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share Marinus Pharma (MRNS)|NKGN: Book Value per Share|NRBO - Net Asset Value per Share|Sage Therapeutics - Accounting Value per Share|SNPX: Book Value per Share|Net Assets per Single Share Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value of a Share|Net Assets per Single Share WENA (Anew Medical)|Net Asset Value per Share cerevel.com